Chemical Space Mapping and Structure–Activity Analysis of the ChEMBL Antiviral Compound Set
- 25 July 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 56 (8) , 1438-1454
Abstract
Curation, standardization and data fusion of the antiviral information present in the ChEMBL public database led to the definition of a robust data set, providing an association of antiviral compounds to seven broadly defined antiviral activity classes. Generative topographic mapping (GTM) subjected to evolutionary tuning was then used to produce maps of the antiviral chemical space, providing an optimal separation of compound families associated with the different antiviral classes. The ability to pinpoint the specific spots occupied (responsibility patterns) on a map by various classes of antiviral compounds opened the way for a GTM-supported search for privileged structural motifs, typical for each antiviral class. The privileged locations of antiviral classes were analyzed in order to highlight underlying privileged common structural motifs. Unlike in classical medicinal chemistry, where privileged structures are, almost always, predefined scaffolds, privileged structural motif detection based on GTM responsibility patterns has the decisive advantage of being able to automatically capture the nature (“resolution detail”—scaffold, detailed substructure, pharmacophore pattern, etc.) of the relevant structural motifs. Responsibility patterns were found to represent underlying structural motifs of various natures—from very fuzzy (groups of various “interchangeable” similar scaffolds), to the classical scenario in medicinal chemistry (underlying motif actually being the scaffold), to very precisely defined motifs (specifically substituted scaffolds).Keywords
This publication has 55 references indexed in Scilit:
- CHEMBL database release 192014
- Dancing with chemical formulae of antivirals: A panoramic view (Part 2)Biochemical Pharmacology, 2013
- Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009-April 2010)Clinical Infectious Diseases, 2010
- Design of Inhibitors of Orotidine Monophosphate Decarboxylase Using Bioisosteric Replacement and Determination of Inhibition KineticsJournal of Medicinal Chemistry, 2006
- Design and Synthesis of Novel 5-Substituted Acyclic Pyrimidine Nucleosides as Potent and Selective Inhibitors of Hepatitis B VirusJournal of Medicinal Chemistry, 2002
- Developments of the generative topographic mappingNeurocomputing, 1998
- RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVALAnnual Review of Microbiology, 1997
- Three-dimensional Structure of Influenza A N9 Neuraminidase and Its Complex with the Inhibitor 2-Deoxy 2,3-Dehydro-N-Acetyl Neuraminic AcidJournal of Molecular Biology, 1993
- Syntheses and biological evaluations of 3'-deoxy-3'-C-branched-chain-substituted nucleosidesJournal of Medicinal Chemistry, 1993
- The membrane protein of influenza virus: Extraction from virus and infected cell with acidic chloroform—MethanolVirology, 1973